Page 82 - Screening for Cervical Cancer: Systematic Evidence Review
P. 82

References



                 66.   Bollen LJ, Tjong-A-Hung SP, van der Velden J, et al. Human papillomavirus
                              deoxyribonucleic acid detection in mildly or moderately dysplastic smears: a
                              possible method for selecting patients for colposcopy. Am J Obstet Gynecol.
                              1997;177:548-553.

                 67.   Sigurdsson K, Arnadottir T, Snorradottir M, Benediktsdottir K, Saemundsson H. Human
                              papillomavirus (HPV) in an Icelandic population: the role of HPV DNA testing
                              based on hybrid capture and PCR assays among women with screen-detected
                              abnormal pap smears. Int J Cancer. 1997;72:446-452.

                 68.   Manos MM, Kinney WK, Hurley LB, et al. Identifying women with cervical neoplasia:
                              using human papillomavirus DNA testing for equivocal Papanicolaou results. J
                              Am Med Assoc.  1999;281:1605-1610.

                 69.   Herrington CS, Evans MF, Hallam NFeal. Human papillomavirus status in the prediction
                              of high-grade cervical intra-epithelial neoplasia in patient with persistent low-
                              grade cervical cytological abnormalities. Br J Cancer. 1995;71:206-209.

                 70.   Cuzick J, Sasieni P, Davies P, et al. A systematic review of the role of human
                              papillomavirus testing within a cervical screening programme. Health Technol
                              Assess. 1999;3:i-iv, 1-196.

                 71.   Adam E, Kaufman RH, Berkova Z, Icenogle J, Reeves WC. Is human papillomavirus
                              testing an effective triage method for detection of high-grade (grade 2 or 3)
                              cervical intraepithelial neoplasia? Am J Obstet Gynecol. 1998;178:1235-1244.

                 72.   Hillemanns P, Kimmig R, Huttemann U, Dannecker C, Thaler CJ. Screening for cervical
                              neoplasia by self-assessment for human papillomavirus DNA. Lancet.
                              1999;354:1970.

                 73.   Sun XW, Ferenczy A, Johnson D, et al. Gynecology: Evaluation of the Hybrid Capture
                              human papillomavirus deoxyribonucleic acid detection test. Am J Obstet Gynecol.
                              1995;173:1432-1437.

                 74.   Kavanagh AM, Broom DH. Women's understanding of abnormal cervical smear test
                              results:  a qualitative interview study. Br Med J. 1997;1388-1391.

                 75.   Lauver D, Rubin M. Women's concerns about abnormal Papanicolaou test results.
                              JOGNN. 1990;20:154-159.


                 76.   Barsevick AM, Lauver D. Women's informational needs about coploscopy. IMAGE:  J
                              Nurs Scholarship. 1990;22:23-26.

                 77.   Stewart DE, Lickrish GM, Sierra S, Parkin H. The effect of educational brochures on
                              knowledge and emotional distress in women with abnormal Papanicolaou smears.
                              Obstet Gynecol. 1993;81:280-282.

                 78.   Somerset M, Peters TJ. Intervening to reduce anxiety for women with mild dyskaryosis:




                                                             88
   77   78   79   80   81   82   83   84   85   86   87